Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin.
Yang YS, Chin YT, Hsieh MT, Lai HY, Ke CC, Crawford DR, Lee OK, Fu E, Mousa SA, Grasso P, Liu LF, Chang HY, Tang HY, Lin HY, Davis PJ.
Yang YS, et al. Among authors: tang hy.
Oncotarget. 2017 May 23;8(21):35480. doi: 10.18632/oncotarget.18067.
Oncotarget. 2017.
PMID: 28545220
Free PMC article.
No abstract available.